New patent expiration for Gilead drug CAYSTON

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for CAYSTON
Annual Drug Patent Expirations for CAYSTON

Cayston is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has forty-four patent family members in twenty-one countries.

The generic ingredient in CAYSTON is aztreonam. One supplier is listed for this compound. Additional details are available on the aztreonam profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top